PT9 Evaluating Healthcare Costs and Demographics of Medicare Part D Beneficiaries Impacted by First Top 10 Drugs Selected for Price Negotiations Under the Inflation Reduction Act (IRA).

Autor: Varghese, I1 (AUTHOR), Celli, J1 (AUTHOR), Kardel, P1 (AUTHOR), Liu, Z1 (AUTHOR), Sheetz, C1 (AUTHOR)
Zdroj: Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS348-S348. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: